Report
Michael Waterhouse
EUR 100.00 For Business Accounts Only

Dr. Reddy's Low Cost Operations and Emerging Market Brand Recognition Should Bolster Performance

Dr. Reddy's fiscal second-quarter results provided no major surprises to us. We don't anticipate making major changes to our fair value estimate, and we’re also reiterating our no-moat rating.
The company's global generic revenue was mixed across regions during the quarter. The segment's overall revenue grew by roughly 7% thanks to emerging-market performance, and we think Dr. Reddy's relative brand recognition in emerging markets will continue to bode well for its performance. The company exper...
Underlying
Dr. Reddy's Laboratories Ltd. ADS

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Michael Waterhouse

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch